openPR Logo
Press release

At a CAGR of 6.7%, Thrombosis Drugs Market Size Will Estimated to Reach USD 51.5 Billion by 2031 | TMR Research

07-31-2024 01:37 PM CET | Health & Medicine

Press release from: Transparency Market Research

Thrombosis Drugs Market

Thrombosis Drugs Market

Thrombosis is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system. It can lead to serious conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke. Effective treatment and prevention of thrombosis are critical to reduce morbidity and mortality. This article explores the current state, trends, and future prospects of the thrombosis drugs market.

Thrombosis Drugs Market (혈전증 약물 시장) is estimated to grow at a CAGR of 6.7% from 2023 to 2031 and reach US$ 51.5 Bn by the end of 2031

Request a PDF Sample of this Report Now!
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=46293

Overview of Thrombosis Drugs Market
The global thrombosis drugs market is growing due to an increasing prevalence of thrombotic disorders, advancements in anticoagulant therapies, and a rising awareness of the importance of early detection and treatment. The market is segmented by drug type (anticoagulants, antiplatelet drugs, thrombolytics, others), indication (DVT, PE, atrial fibrillation, myocardial infarction, others), route of administration (oral, injectable), distribution channel (hospital pharmacies, retail pharmacies, online pharmacies), and geographical regions.

Top Companies:

GSK plc
Baxter International Inc.
Johnson & Johnson
Sanofi
Bristol-Myers Squibb Company
AstraZeneca plc
Bayer AG
Aspen Pharmacare Holdings Limited
Boehringer Ingelheim GmbH Pfizer, Inc.

Recent Developments in Thrombosis Drugs Market
Recent advancements and trends in the thrombosis drugs market include:

Novel Oral Anticoagulants (NOACs): Development and increasing use of NOACs such as rivaroxaban, apixaban, and dabigatran, which offer advantages over traditional warfarin in terms of safety and ease of use.
Combination Therapies: Exploration of combination therapies that incorporate anticoagulants with antiplatelet drugs to enhance efficacy in preventing thrombotic events.
Biosimilars: Introduction of biosimilars for established anticoagulants, providing cost-effective treatment options.
Personalized Medicine: Growth in personalized medicine approaches to tailor thrombosis treatments based on individual patient risk profiles and genetic factors.
Extended-Release Formulations: Development of extended-release formulations to improve patient compliance by reducing the frequency of dosing.

Drivers of Market Growth
Several factors contribute to the growth of the thrombosis drugs market:

Rising Incidence of Thrombotic Disorders: Increasing prevalence of conditions such as DVT, PE, atrial fibrillation, and cardiovascular diseases driving the demand for thrombosis drugs.
Aging Population: Aging population more susceptible to thrombotic disorders due to age-related changes in the coagulation system and increased prevalence of comorbidities.
Advancements in Anticoagulant Therapy: Continuous advancements in anticoagulant therapies enhancing the efficacy and safety of thrombosis treatments.
Increased Awareness: Growing awareness about the importance of early detection and treatment of thrombotic disorders among healthcare professionals and patients.
Improved Diagnostic Technologies: Advancements in diagnostic technologies facilitating early and accurate diagnosis of thrombotic conditions, leading to timely treatment.

Download PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=46293

Conclusion

The thrombosis drugs market is poised for significant growth, driven by rising incidence of thrombotic disorders, aging population, advancements in anticoagulant therapy, increased awareness, and improved diagnostic technologies. Innovations in NOACs, combination therapies, biosimilars, personalized medicine, and extended-release formulations are enhancing the potential and efficacy of thrombosis treatments.

Market Segmentation

Drug Class
Factor Xa Inhibitor
Low Molecular Weight Heparin
P2Y12 Platelet Inhibitor
Others

Indication
Pulmonary Embolism
Atrial Fibrillation
Deep Vein Thrombosis
Others

Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Regions Covered
North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=46293<ype=S

More Trending Reports by Transparency Market Research -

Cryotherapy Market (Marché de la cryothérapie): https://www.globenewswire.com/en/news-release/2024/07/03/2908096/32656/en/Cryotherapy-Market-to-be-Worth-USD-885-7-million-by-2034-Growing-a-CAGR-9-3-Exclusive-Report-by-Transparency-Market-Research-Inc.html

Urinary Tract Disorders Propels Ureteral Stents Market (尿路疾患が尿管ステント市場を牽引): https://www.globenewswire.com/news-release/2024/07/05/2909009/32656/en/Rising-Incidence-of-Urinary-Tract-Disorders-Propels-Ureteral-Stents-Market-to-Achieve-USD-823-7-Million-by-2031-Transparency-Market-Research-Inc.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release At a CAGR of 6.7%, Thrombosis Drugs Market Size Will Estimated to Reach USD 51.5 Billion by 2031 | TMR Research here

News-ID: 3605687 • Views:

More Releases from Transparency Market Research

Acromegaly Treatment Market to Reach USD 3.1 Billion by 2035, Driven by Diagnostic Advancements, Oral Drug Innovations, and Rising Disease Awareness | TMR
Acromegaly Treatment Market to Reach USD 3.1 Billion by 2035, Driven by Diagnost …
The global Acromegaly Treatment Market is experiencing a significant transformation as improved early diagnosis, innovative therapeutic formulations, and regulatory support converge to expand patient access and drive substantial growth. According to the latest industry analysis, the global market, valued at US$ 1.5 billion in 2024, is projected to reach US$ 3.1 billion by 2035, progressing at a CAGR of 6.7% from 2025 to 2035. Gain a preview of important insights from
Forensic Genomics Market Projected to Surge to USD 2.4 Billion by 2035 as NGS, AI/ML Bioinformatics and Portable DNA Devices Transform Criminal Investigations | TMR
Forensic Genomics Market Projected to Surge to USD 2.4 Billion by 2035 as NGS, A …
The global Forensic Genomics Market is undergoing a period of accelerated transformation and expansion as next-generation sequencing (NGS), advanced PCR workflows, and AI/ML-driven bioinformatics redefine the capabilities of modern forensic investigations. According to the latest industry analysis, the market-valued at US$ 0.5 billion in 2024-is projected to reach approximately US$ 2.4 billion by 2035, expanding at a compound annual growth rate (CAGR) of 14.5% between 2025 and 2035. Access key findings
Planetary Roller Screw Market to Reach USD 1.1 Billion by 2035 as Demand for High-Load, High-Precision Actuation Systems Accelerates Worldwide | TMR
Planetary Roller Screw Market to Reach USD 1.1 Billion by 2035 as Demand for Hig …
The global Planetary Roller Screw Market is poised for substantial expansion over the next decade, driven by rising demand for high-load, high-precision performance in harsh industrial environments, rapid technological advancements, and the ongoing global shift toward electrified and automated systems. According to the latest industry intelligence, the market-valued at US$ 610.0 Mn in 2024-is projected to reach US$ 1,105.0 Mn by 2035, advancing at a compound annual growth rate (CAGR)
Chemical Absorbent Cotton Market Set to Reach USD 600.1 Million by 2035 Driven by Sustainability Initiatives, Regulatory Compliance, and Rising Industrial Demand
Chemical Absorbent Cotton Market Set to Reach USD 600.1 Million by 2035 Driven b …
The global Chemical Absorbent Cotton Market is entering a phase of sustained expansion, backed by rapid industrialization, strengthened environmental regulations, and growing adoption of biodegradable absorbent solutions across healthcare, chemical handling, automotive, and industrial safety applications. According to the latest industry analysis, the global market-valued at US$ 340.0 million in 2024-is projected to reach US$ 600.1 million by 2035, expanding at a CAGR of 5.4% from 2025 to 2035. Access key

All 5 Releases


More Releases for Thrombosis

Rising Demand For Deep Vein Thrombosis (DVT) Treatment Drives Market Growth: Key …
The Deep Vein Thrombosis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Deep Vein Thrombosis Market Size During the Forecast Period? The Deep Vein Thrombosis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025
Deep Vein Thrombosis Market Size, Share, Development By 2033
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033 The Business Research Company offers in-depth market insights through Deep Vein Thrombosis Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments. Market Size And Growth Forecast: The deep vein thrombosis market size has grown steadily in recent
Thrombosis Drug Market Stunning Value Ahead | GlaxoSmithKline , Baxter, Johnson …
The latest study released on the Global Thrombosis Drug Market by HTF MI evaluates market size, trend, and forecast to 2029. The Thrombosis Drug market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors. Key Players in
Thrombosis Drugs Market to Eyewitness Massive Growth by 2032
Thrombosis, the formation of blood clots within blood vessels, is a condition that can have serious and life-threatening consequences. In the quest to combat this medical challenge, the Thrombosis Drugs Market plays a vital role in shaping the dynamics from initial research to patient recovery. This article dives deep into the evolving landscape of thrombosis treatment, highlighting the progress, challenges, and the critical role of research in achieving recovery. 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞
Thrombosis Associated with Cancer Market Insights, Forecast to 2030
Thrombosis Associated with Cancer Market 2021 by Technology, Manufacturers, Regions, Type, and Application, Forecast guide to light the excellent analysis on the market synopsis. The report offers a primary focus on important factors in the global Thrombosis Associated with Cancer industry. The report includes perceptive information about gross revenue, cost, value, capacity, pricing, and profit margins concerning historical analysis and forecast estimation for the 2021 to 2031 time period. It
Thrombosis Drugs Market
“Thrombosis Drugs Market” study by “The Insight Partners” provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years. This Report encloses comprehensive analysis on the market and are assessed through volume and value data validated on three approaches including top companies revenues. It concludes with precise and authentic market